Lamotrigine Tablet
Product Images NDC 70518-2563

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-2563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Lamotrigine 100 mg oral tablet packaging label from RemedyRepack Inc. The label indicates a quantity of 30 tablets and includes the product NDC 70518-2563-00. It lists the manufacturer as Zydus Pharm, Pennington, NJ, and provides storage instructions for 20-25°C with allowable excursions. The label directs users to see the package insert for directions and includes a QR code and lot information fields.*

FDA Label Image

A8e89916 Ae5a 48af 9da1 8b9288d977fd 388 2

Lamotrigine 100 mg oral tablet imprint showing 'ZC 79' on a white, round tablet. The tablet is manufactured by RemedyRepack Inc. and is used as a human prescription drug.*

FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 01

Chemical structure diagram of lamotrigine, illustrating its molecular framework with chlorine atoms and nitrogen-containing rings as part of the active ingredient's chemical composition.*

FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 02

A Kaplan-Meier failure probability plot comparing Lamotrigine and placebo over approximately 90 weeks. The vertical axis shows failure probability as a percentage, and the horizontal axis shows time in weeks. Two curves represent failure probabilities for Lamotrigine and placebo groups, with censoring events marked.*

FDA Label Image

Fd77496d 56c7 476b 9231 0298034b1a17 03

A Kaplan-Meier failure probability curve comparing Lamotrigine and Placebo over approximately 80 weeks. The y-axis shows failure probability in percentage, and the x-axis shows time in weeks. The chart includes censored data points marked with plus signs. Two lines represent failure probabilities for Lamotrigine and Placebo groups over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.